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In elderly populations, frailty is associated with higher mortality risk. Although many frailty scores (FS) have been
proposed, no single score is considered the gold standard. We aimed to evaluate the agreement between a wide
range of FS in the English Longitudinal Study of Ageing (ELSA). Through a literature search, we identiﬁed 35 FS
that could be calculated in ELSA wave 2 (2004–2005). We examined agreement between each frailty score and
the mean of 35 FS, using a modiﬁed Bland-Altman model and Cohen’s kappa (κ). Missing data were imputed. Data
from 5,377 participants (ages ≥60 years) were analyzed (44.7% men, 55.3% women). FS showed widely differing
degrees of agreement with the mean of all scores and between each pair of scores. Frailty classiﬁcation also
showed a very wide range of agreement (Cohen’s κ = 0.10–0.83). Agreement was highest among “accumulation
of deﬁcits”-type FS, while accuracy was highest for multidimensional FS. There is marked heterogeneity in the
degree to which various FS estimate frailty and in the identiﬁcation of particular individuals as frail. Different FS are
based on different concepts of frailty, and most pairs cannot be assumed to be interchangeable. Research results
based on different FS cannot be compared or pooled.
accuracy; agreement; Bland-Altmanmodel; Cohen’s kappa coefﬁcient; disability; elderly population; frailty scores;
reliability
Abbreviations: ELSA, English Longitudinal Study of Ageing; FS, frailty scores; M35FS, mean of the 35 analyzed frailty scores.
Vulnerable elderly individuals are increasingly described
in the literature as being frail—that is, having a decreased ability
to recover from an adverse event (1). Three main approaches
have been used to conceptually deﬁne frailty.
The ﬁrst approach is the “phenotype of frailty” (2), which
is a physiological model focused mainly on physical frailty
and which describes frailty as a phenomenon of “weakness,
decreased endurance and slow performance” (2, p. 154). This
approach regards frailty as separate from disability and comor-
bidity. The operational deﬁnition of this approach deﬁnes
frailty as the presence of at least 3 out of 5 criteria (prefrailty: 1
or 2 criteria). The second approach is “accumulation of deﬁ-
cits” (3), which is based on the accumulation of conditions or
disabilities, emphasizing the number rather than the nature of
deﬁcits. The operational deﬁnition of this approach deﬁnes
frailty with at least 30 variables (4) and includes disability and
comorbidity (5). The third approach is the “multidimensional
model” (6), which deﬁnes frailty as a dynamic state of loss
affecting 1 or more areas of functioning, such as the cognitive,
physical, and social domains. Finally, some frailty scores (FS)
have been operationalizedmainly as the presence of disability.
Frailty is associated with a higher risk of mortality, dis-
ability, falls, fractures, hospitalization, and institutionaliza-
tion (7, 8). Some evidence indicates that exercise, caloric and
protein support, vitamin D supplementation, and reduction
of polypharmacy can be effective in preventing the progres-
sion of frailty and the occurrence of its adverse outcomes (9).
Consequently, it is important to identify frail individuals and
persons at risk at an early stage (7). However, it remains
unclear which tool is best suited for this purpose.
The ability of FS to accurately produce stable and reproduc-
ible results has been partially studied (10). In a systematic
review of FS, Bouillon et al. (11) found that 7 out of 27 scores
had been assessed for both reliability and concurrent or predic-
tive validity. In a recent study that assessed the validity and
reproducibility of 8 commonly used FS in an elderly European
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general population, Theou et al. (12) found that the prevalence
of frailty varied from 6.1% to 43.9%; across all 8 scales, 49.3%
of participants were classiﬁed as nonfrail and 2.4% were classi-
ﬁed as frail. The authors concluded that FS have signiﬁcant dif-
ferences regarding validity, feasibility, and predictive ability (12).
The absence of consensus on how to conceptually deﬁne
frailty and the resulting plethora of scales and scores cur-
rently hampers both research in the ﬁeld and implementation
of frailty assessment in clinical practice. In order to enable
comparison of studies of frailty performed with different FS
and to facilitate the choice of FS for future studies, it is essen-
tial to quantify the degree of agreement between scores and
to understand the sources of disagreement.
Based on the hypothesis that different FS may classify dif-
ferent subsets of a population as frail, we set out to study the
agreement between a wide set of FS in a well-characterized
cohort of elderly people: participants in the English Longitu-
dinal Study of Ageing (ELSA).
METHODS
Study population/design
ELSA is an ongoing cohort study based on a large, nation-
ally representative sample of the middle-aged and elderly (ages
≥50 years) English population. Information about participants
Table 1. General Characteristics of Participants (n= 5,377) inWave 2 of the English Longitudinal Study of Ageing,
2004–2005
Characteristic
Men (n= 2,401) Women (n= 2,976)
Mean (SD) % Mean (SD) %
Age, yearsa 70.8 (7.6) 71.5 (8.2)b
Bodymass indexc,d,e 27.7 (4.1) 28.0 (5.2)
Total cognitive score (per point)d,e,f 26.7 (6.4) 27.6 (6.7)b
Marital status (currently married)d,g 75.0 52.8b
Education (no high school qualiﬁcation)d,g 37.3 48.7b
Smoking statusd,g
Current smoker 12.8 11.9b
Former smoker 61.9 43.5b
Never smoker 25.4 44.6b
Physical activityd,g,h
None (sedentary) 6.6 7.9b
Mild 22.7 30.9b
Moderate 50.9 48.7b
Vigorous 19.8 12.5b
Chronic diseasei,j
Diabetes 11.4 8.4b
Hypertension 46.3 49.6b
Myocardial infarction 11.6 4.9b
Stroke 6.9 5.8
Cancer 8.4 9.8
Lung disease 8.5 8.4
Arthritis 33.6 50.7b
Depression symptoms (CES-D score≥4)d,g,k 25.7 37.1b
Abbreviations: CES-D, Center for Epidemiologic Studies Depression Scale; SD, standard deviation.
a P value was derived from an unpaired t test.
b P< 0.05.
c Weight (kg)/height (m)2.
d Imputed data.
e Linear regressionmodel.
f Sum of memory and executive indices; values range from 0 (worst) to 50 (best).
g Logistic regression.
h Self-reported frequency of mild, moderate, or vigorous activity at least once per week.
iP value was derived from a χ2 test.
j Self-reported ever diagnosis of the condition.
k Assessed by means of the 8-itemCES-D.
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Table 2. Characteristics of Frailty Scores Calculated Among Participants inWave 2 of the English Longitudinal Study of Ageing, 2004–2005
First Author, Year
(Reference No.) Frailty Measure Country Model Aim
Deﬁnition of
Score
No. of Variables
Deﬁneda
No. of Variables
Calculatedb
% of
Missing Datac
Klein, 2003 (23) Beaver DamEye Study Index United States POF CD Continuous 4 4 26.5
Gill, 2002 (24) Physical Frailty Index United States POF CS Categorical 2 2 19.1
Cesari, 2014 (25) FiNDQuestionnaire France POF CD Binary 5 5 1.3
Abellan van Kan, 2008 (26) Frail Scale France POF CS Categorical 5 5 1.3
Fried, 2001 (2) Phenotype of Frailty United States POF CD Categorical 5 5 13.4
Rothman, 2008 (27) Modiﬁed Phenotype of Frailty United States POF CD Continuous 7 7 15.8
Ensrud, 2007 (28) Study of Osteoporotic Fractures United States POF CS Categorical 3 3 14.3
Guralnik, 1994 (29) Short Physical Performance Battery United States POF CD Binary 3 3 21.8
Chin, 1999 (30) ZED1 (Physical Activity and Low
Energy)
Netherlands POF CD Binary 2 2 0.5
Chin, 1999 (30) ZED2 (Physical Activity andWeight
Loss)
Netherlands POF CD Binary 2 2 0.8
Chin, 1999 (30) ZED3 (Physical Activity and Low BMI) Netherlands POF CD Binary 2 2 4.7
Freiheit, 2010 (31) Brief Frailty Index Canada MD CS Binary 5 5 17.3
Hubbard, 2009 (32) Modiﬁed Frailty Score United
Kingdom
MD CS Categorical 5 5 21.6
Balducci, 2000 (33) CGAST United States MD CS Categorical 9 9 10.4
Ravaglia, 2008 (34) Conselice Study of Brain Aging Score Italy MD CD Binary 9 9 23.4
Rolfson, 2006 (35) Edmonton Frail Scale Canada MD CS Binary 9 9 12.6
Cacciatore, 2005 (36) Frailty Staging System Italy MD CS Categorical 7 7 3.5
Bellera, 2012 (37) G-8 geriatric screening tool France MD CS Categorical 8 7 4.2
Steverink, 2001 (38) Groningen Frailty Indicator Netherlands MD CS Binary 11 11 14.3
Brody, 1997 (39) Health Status Form United States MD CD Continuous 4 4 11.9
Puts, 2005 (40) Static/Dynamic Frailty Index Netherlands MD CD Binary 9 9 25.3
Maly, 1997 (41) Screening Instrument United States MD CD Binary 6 6 11.3
Hábert, 1996 (42) Sherbrooke Postal Questionnaire Canada MD CD Binary 6 6 14.4
Di Bari, 2014 (43) Inter-Frail Questionnaire Italy MD CD Binary 10 8 14.8
Gobbens, 2010 (44) Tilburg Frailty Indicator Netherlands MD CD Binary 15 15 22.1
Jones, 2004 (45) Comprehensive Geriatric Assessment Canada AOD CD Categorical 44 41 35.1
de Vries, 2013 (46) Evaluative Frailty Index for Physical
Activity
Netherlands AOD CD Continuous 50 42 22.8
Searle, 2008 (4) 40-item Frailty Index Canada AOD CD Binary 40 37 23.7
Theou, 2013 (47) 70-item Frailty Index (SHARE) Canada AOD CD Binary 70 62 40.5
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is gathered at 2-year intervals (waves). All waves include
administration of questionnaires concerning health determi-
nants and physical and mental health. In addition, in waves 2,
4, and 6, participants underwent a clinical examination.
Ethical approval was obtained from the National Health
Service Research Ethics Committee. Participants gave signed
informed consent (13). ELSA data were accessed via the UK
Data Service.
We carried out a cross-sectional analysis of data from wave
2 (2004–2005) of ELSA, as this was the ﬁrst wave in which a
comprehensive assessment of frailty indicators was performed.
Since not all frailty-related variables were measured in partici-
pants under age 60 years, we restricted our analyses to those
aged 60 years or more.
Identiﬁcation and selection of FS
A PubMed search of the literature was performed (date
range: January 1, 1970–August 31, 2015) with the following
query: “((frailty [Title/Abstract]) AND score [Title/Abstract]).”
Abstracts were checked for the publication of an original frailty
score. Furthermore, FS were identiﬁed on the basis of refer-
ences from recent review articles (11, 14–16). Published FS
were selected for inclusion if at least 80% of the component
variables were available in ELSA wave 2. If information on 1
or more underlying variables (maximally 20%) comprising a
score was unobtainable from the data, the frailty score was cal-
culated based on the available variables and the total score and
the cutoff were reﬁtted to the actual number of variables (17).
Variables for which data were unavailable due to the ELSA
study design were not imputed.
FS were calculated while trying to be faithful to the origi-
nal scores. However, it was necessary to tailor some vari-
ables to the data. For some FS, this adaptation was based on
previous publications (12). FS vary in yielding continuous,
categorical, or binary outputs, each with different ranges.
Each score was rescaled to the interval 0–1 by dividing the
original score output by the highest possible value for each
score. Some scores were additionally inverted ((rescaled
score × −1) + 1) to conform to our deﬁnition of 0 represent-
ing the absence of frailty and 1 representing its presence.
Missing data
If data from an available underlying variable in ELSA were
missing for some participants, multiple imputation was
applied (18). The amount of missing data varied from 0.04%
to 24.7%.
The maximum percentage of missing data was used to
decide how many imputations to perform (19). Therefore,
we imputed 30 times, using chained equations (the “mice”
package in R (20)). To obtain optimally plausible values for
the scores, we applied imputation to the original underlying
variables and calculated FS a posteriori using imputed
values.
All statistical analyses were performed on the 30 imputed
data sets, and resulting estimates were pooled according to
the Rubin rules (18, 21). All results presented in this paper
were obtained on the basis of the multiple imputation proce-
dure described above.Ta
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Table 3. Prevalence of Frailty Among Participants inWave 2 of the English Longitudinal Study of Ageing, 2004–2005
Frailty Model andMeasure Published Cutoff Cutoff Used
Men Women
%Not Frail % Prefrail % Frail % Not Frail % Prefrail % Frail
“Phenotype of frailty”model
Beaver DamEye Study Index None NA NA NA NA NA NA NA
Physical Frailty Index >1 and>0 >1 and>0 81.9 14.9 3.2 73.8 20.4 5.8
FiNDQuestionnairea ≥1 ≥1 60.3 NA 39.7 52.3 NA 47.7
Frail Scale >2;>0 >2;>0 61.5 31.2 7.4 53.1 38.0 8.9
Phenotype of Frailty ≥3;≥1 ≥3;≥1 11.7 75.8 12.5 6.6 78.6 14.8
Modiﬁed Phenotype of Frailty None NA NA NA NA NA NA NA
Study of Osteoporotic Fractures ≥2;≥1 ≥2;≥1 67.6 25.6 6.8 60.4 30.2 9.4
Short Physical Performance Battery ≤9 ≤9 35.0 NA 65.0 29.0 NA 71.0
ZED1 (Physical Activity and LowEnergy) >1 >1 96.3 NA 3.7 95.5 NA 4.5
ZED2 (Physical Activity andWeight Loss) >1 >1 98.1 NA 1.9 97.0 NA 3.0
ZED3 (Physical Activity and LowBMI) >1 >1 99.2 NA 0.8 99.0 NA 1.0
Multidimensional model
Brief Frailty Index ≥3 ≥3 91.0 NA 9.0 82.8 NA 17.2
Modiﬁed Frailty Score >2;>0 >2;>0 20.0 16.3 63.7 12.9 18.6 68.5
CGAST >2;>0 >2;>0 17.6 49.0 33.4 12.4 45.9 41.7
Conselice Study of Brain Aging Score ≥3 ≥3 47.3 NA 52.7 65.2 NA 34.8
Edmonton Frail Scale ≥8 ≥8 96.7 NA 3.3 95.2 NA 4.8
Frailty Staging System ≥4;≥2 ≥4;≥2 58.2 30.6 11.2 50.6 34.4 15.0
G-8 geriatric screening tool ≤14 ≤12 37.9 NA 62.1 27.6 NA 72.4
Groningen Frailty Indicator ≥4 ≥4 64.8 NA 35.2 55.9 NA 44.1
Health Status Form None NA NA NA NA NA NA NA
Static/Dynamic Frailty Index ≥3 ≥3 65.7 NA 34.3 45.7 NA 54.3
Screening Instrument ≥3 ≥3 95.6 NA 4.4 92.1 NA 7.9
Sherbrooke Postal Questionnaire ≥2 ≥2 81.3 NA 18.7 71.7 NA 28.3
Inter-Frail Questionnaire ≥5 ≥5 98.4 NA 1.6 97.2 NA 2.8
Tilburg Frailty Indicator ≥5 ≥5 64.1 NA 35.9 53.3 NA 46.7
“Accumulation of deﬁcits”model
Comprehensive Geriatric Assessment ≥7;≥13 ≥6;≥12 57.8 30.7 11.5 42.1 40.2 17.7
Evaluative Frailty Index for Physical Activity None NA NA NA NA NA NA NA
40-item Frailty Index >0.2 >0.2 68.8 NA 31.2 56.7 NA 43.3
70-item Frailty Index (SHARE) ≥0.25 ≥0.25 74.7 NA 25.3 62.7 NA 37.3
Frailty Index (BLSA) None NA NA NA NA NA NA NA
Long TermCare Survey Frailty Index None NA NA NA NA NA NA NA
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Statistical analyses
The prevalence of frailty was calculated for each frailty
score prior to rescaling using the original, published cutoff
points. To enable comparisons between scores, we calculated
the mean value, median value, and standard deviation and all
further analyses on the rescaled scores in the total population
and also stratiﬁed by sex, age, and smoking status.
Agreement was analyzed using 3 parallel methods:
1. The modiﬁed Bland-Altman model (22). In the absence
of an external gold standard for frailty, we chose the
mean of the 35 analyzed FS (M35FS) as a global esti-
mate of “true frailty.” The error (the difference between
each score and the M35FS) was plotted on the y-axis
against the M35FS on the x-axis. Linear regression was
used to calculate the dependence of each score’s error
(over- or underestimation) on the severity of frailty, as
well as to calculate its limits of agreement. The degree
of under-/overestimation was estimated at the median
of the M35FS (model A).
2. Traditional pairwise Bland-Altman models. Traditional
pairwise Bland-Altman models were built comparing all
595 possible pairs of FS. The error (the difference be-
tween each score and the mean of the 2 compared FS) was
plotted on the y-axis against a rough estimate of the “true
frailty,” deﬁned as the mean of the 2 FS, on the x-axis.
The width of prediction intervals and the absolute error
(calculated at the median point on the x-axis) were ana-
lyzed (model B).
3. Cohen’s kappa (κ). In order to enable comparisons across
all 595 possible pairs of 35 FS in spite of different underly-
ing concepts of frailty, different cutoff points, and the
absence of a published cutoff point in some cases, we
also calculated κ applying an arbitrary cutoff across all
scores (deﬁning the highest 20% of scores as “frail”). In
cases where a score category straddled the 20% cutoff
level, κ was calculated using a 20-bootstrap resample
procedure, which classiﬁed participants from the strad-
dling category randomly as frail/nonfrail in the propor-
tion necessary to achieve an overall 20% prevalence of
frailty. We calculated 95% conﬁdence intervals for κ on
the basis of Rubin’s method for covariance and conﬁ-
dence interval calculation in imputed data. The mean
within-imputation variance, the between-imputations
variance, the total variance, and ﬁnally the conﬁdence
intervals were calculated (21).
FS were grouped into 4 main operationalization models:
“phenotype of frailty” for scores based mainly on physi-
cal functioning variables; “accumulation of deﬁcits” for
scores based on various domains and at least 30 vari-
ables; “multidimensional model” for scores that analyzed
at least 3 domains of functioning and included fewer than
30 variables; and “disability model” for scores based
mainly on disability variables. FS were also grouped ac-
cording to the stated target population: community-dwelling
or clinical setting.
In addition, to assess agreement with regard to a binary or
categorical deﬁnition of frailty, κ was calculated for pairs of
FS with a published cutoff level (29 out of 35 FS).Ta
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Table 4. Rescaled (0–1) Mean (Standard Deviation)a Frailty Scores andPValues for Differencesb Between Frailty Scores, Overall and by Sex, Age, and Smoking Status, Among Participants
inWave 2 of the English Longitudinal Study of Ageing, 2004–2005
Frailty Model andMeasure Total
Sex Age Smoking Status
Malec Female ≤70 Yearsc >70 Years Never Smokerc Ex-Smoker Current Smoker
“Phenotype of frailty”model
Beaver DamEye Study Index 0.37 (0.27) 0.37 (0.26) 0.38 (0.28) 0.26 (0.23) 0.49 (0.26)d 0.35 (0.27) 0.37 (0.27)d 0.42 (0.25)d
Physical Frailty Index 0.14 (0.27) 0.11 (0.24) 0.16 (0.29)d 0.07 (0.19) 0.21 (0.32)d 0.13 (0.27) 0.14 (0.27) 0.15 (0.28)
FiNDQuestionnaire 0.23 (0.23) 0.20 (0.22) 0.25 (0.24)d 0.18 (0.20) 0.28 (0.25)d 0.21 (0.22) 0.23 (0.23)d 0.28 (0.24)d
Frail Scale 0.14 (0.20) 0.13 (0.19) 0.16 (0.21)d 0.11 (0.17) 0.19 (0.22)d 0.13 (0.20) 0.15 (0.20)d 0.19 (0.22)d
Phenotype of Frailty 0.30 (0.24) 0.27 (0.23) 0.32 (0.24)d 0.23 (0.20) 0.38 (0.25)d 0.28 (0.23) 0.30 (0.23)d 0.34 (0.25)d
Modiﬁed Phenotype of Frailty 0.33 (0.23) 0.27 (0.23) 0.35 (0.23)d 0.25 (0.20) 0.41 (0.24)d 0.31 (0.23) 0.33 (0.23)d 0.38 (0.24)d
Study of Osteoporotic Fractures 0.15 (0.22) 0.13 (0.21) 0.17 (0.23)d 0.11 (0.19) 0.20 (0.25)d 0.14 (0.22) 0.15 (0.22) 0.19 (0.24)d
Short Physical Performance Batterye 0.34 (0.19) 0.32 (0.17) 0.35 (0.20)d 0.26 (0.15) 0.42 (0.20)d 0.33 (0.19) 0.34 (0.19) 0.34 (0.19)
ZED1 (Physical Activity and LowEnergy) 0.32 (0.28) 0.29 (0.27) 0.35 (0.28)d 0.27 (0.25) 0.38 (0.29)d 0.30 (0.27) 0.32 (0.28)d 0.39 (0.30)d
ZED2 (Physical Activity andWeight Loss) 0.29 (0.25) 0.27 (0.24) 0.31 (0.25)d 0.24 (0.21) 0.35 (0.27)d 0.29 (0.25) 0.29 (0.24) 0.33 (0.25)d
ZED3 (Physical Activity and LowBMI) 0.27 (0.21) 0.24 (0.20) 0.30 (0.22)d 0.23 (0.19) 0.31 (0.22)d 0.26 (0.21) 0.26 (0.20) 0.33 (0.24)d
Multidimensional model
Brief Frailty Index 0.31 (0.22) 0.27 (0.20) 0.34 (0.23)d 0.25 (0.20) 0.37 (0.22)d 0.29 (0.22) 0.31 (0.22) 0.36 (0.22)d
Modiﬁed Frailty Score 0.34 (0.22) 0.32 (0.22) 0.37 (0.22)d 0.25 (0.19) 0.45 (0.21)d 0.34 (0.22) 0.34 (0.22) 0.38 (0.21)d
CGAST 0.22 (0.16) 0.20 (0.12) 0.24 (0.16)d 0.19 (0.15) 0.26 (0.16)d 0.21 (0.16) 0.23 (0.16)d 0.25 (0.17)d
Conselice Study of Brain Aging Score 0.32 (0.15) 0.37 (0.15) 0.29 (0.15)d 0.26 (0.13) 0.39 (0.15)d 0.30 (0.15) 0.34 (0.16)d 0.34 (0.15)d
Edmonton Frail Scale 0.16 (0.14) 0.15 (0.13) 0.17 (0.14)d 0.13 (0.12) 0.20 (0.14)d 0.15 (0.13) 0.17 (0.13)d 0.19 (0.15)d
Frailty Staging System 0.30 (0.22) 0.28 (0.21) 0.16 (0.21)d 0.22 (0.19) 0.38 (0.23)d 0.28 (0.22) 0.31 (0.22)d 0.32 (0.22)d
G-8 geriatric screening toole 0.21 (0.14) 0.19 (0.14) 0.23 (0.15)d 0.16 (0.12) 0.26 (0.15)d 0.20 (0.15) 0.21 (0.14)d 0.24 (0.15)d
Groningen Frailty Indicator 0.25 (0.16) 0.23 (0.15) 0.26 (0.16)d 0.20 (0.14) 0.26 (0.15)d 0.23 (0.15) 0.25 (0.15)d 0.28 (0.16)d
Health Status Form 0.16 (0.20) 0.14 (0.19) 0.17 (0.21)d 0.08 (0.14) 0.24 (0.23)d 0.14 (0.20) 0.17 (0.21)d 0.16 (0.19)
Static/Dynamic Frailty Index 0.34 (0.17) 0.30 (0.23) 0.37 (0.17)d 0.27 (0.14) 0.41 (0.17)d 0.33 (0.17) 0.33 (0.17) 0.38 (0.17)d
Screening Instrument 0.17 (0.17) 0.13 (0.16) 0.19 (0.18)d 0.14 (0.16) 0.20 (0.18)d 0.16 (0.17) 0.17 (0.17)d 0.19 (0.19)d
Sherbrooke Postal Questionnaire 0.24 (0.17) 0.22 (0.17) 0.26 (0.18)d 0.18 (0.14) 0.30 (0.18)d 0.23 (0.17) 0.24 (0.17) 0.25 (0.17)d
Inter-Frail Questionnaire 0.22 (0.17) 0.22 (0.16) 0.23 (0.17)d 0.16 (0.14) 0.27 (0.17)d 0.21 (0.16) 0.22 (0.17) 0.25 (0.17)d
Tilburg Frailty Indicator 0.33 (0.18) 0.30 (0.16) 0.35 (0.18)d 0.27 (0.15) 0.39 (0.18)d 0.32 (0.17) 0.33 (0.17)d 0.37 (0.18)d
“Accumulation of deﬁcits”model
Comprehensive Geriatric Assessment 0.18 (0.11) 0.16 (0.11) 0.19 (0.12)d 0.15 (0.10) 0.21 (0.12)d 0.17 (0.11) 0.18 (0.11)d 0.20 (0.12)d
Evaluative Frailty Index Physical Activity 0.21 (0.14) 0.19 (0.14) 0.22 (0.15)d 0.17 (0.13) 0.26 (0.15)d 0.19 (0.14) 0.21 (0.14)d 0.24 (0.15)d
40-item Frailty Index 0.20 (0.14) 0.17 (0.13) 0.21 (0.14)d 0.16 (0.12) 0.23 (0.14)d 0.18 (0.14) 0.20 (0.14)d 0.22 (0.15)d
70-item Frailty Index (SHARE) 0.21 (0.14) 0.18 (0.13) 0.23 (0.15)d 0.17 (0.13) 0.25 (0.15)d 0.19 (0.14) 0.21 (0.14)d 0.24 (0.15)d
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RESULTS
We analyzed data from all 5,377 participants aged 60
years or over (44.7% men and 55.3% women) who attended
the ELSA wave 2 clinical examination.
We identiﬁed 67 original FS through the literature search.
Thirty-ﬁve of the 67 scores (52.2%) could be calculated with
ELSAwave 2 data. Web Table 1 (available at https://academic.
oup.com/aje) shows the list of included and excluded FS.Web
Table 2 shows details of all variables for the 35 FS and their
adapted version in the ELSA data set.
Table 1 presents the general characteristics of the study
population by sex.
Table 2 presents the characteristics of the 35 FS that were
analyzed in this study (2, 4, 23–53). The frailty score with
the highest proportion of individual-level missing values
was the 70-item Frailty Index (40.5%), while the lowest propor-
tions of missing values (0.1%) were observed for “WHOAFC
and self-reported health” and the Vulnerable Elders Survey.
Most of the scores (29 of 35) had published cutoffs to deﬁne
frailty.
Prevalence as deﬁned by the published cutoffs varied con-
siderably. The mean prevalence of frailty was 23.1% (standard
deviation, 19.7) for men (range, 0.8–65.0) and 28.9% (stan-
dard deviation, 21.9) for women (range, 1.0–72.4) (Table 3).
Table 4 shows themean frailty score values after rescaling to
the 0–1 range in the whole population globally, as well as strati-
ﬁed by sex, age, and smoking status. Across FS, women, older
participants, and smokers/former smokers were frailer than
men, younger participants, and never smokers, respectively.
Table 5 displays the median κ values. It also shows the
median prediction interval widths and absolute error of under-/
overestimation in analyses based onmodel A andmodel B.
Some FS show over- or underestimation, which can be
seen when the regression line deviates from 0 at the median
point of frailty (0.18) (Web Figure 1). The degree of over- or
underestimation can vary according to frailty level. Some
scores show wider prediction intervals than others. On the
right side of each Bland-Altman plot, a density plot displays
the distribution of the error.
The FS that showed the narrowest prediction interval
widths were the 40-item Frailty Index with model A and the
Comprehensive Geriatric Assessment with model B. Both
FS belong to the “accumulation of deﬁcits”model category.
Figure 1 shows a heat map of κ values for all 595 pairs of
scores. The scores are grouped by frailty model category and
then sorted by each score’s median κ within each category.
The highest κ value was observed for the Evaluative Frailty
Index for Physical Activity (Table 5 and Figure 1). κ values
ranged from 0.10 to 0.83 and were ≥0.80 for 0.8% of pairs,
≥0.60 and <0.80 for 10.4% of pairs, ≥0.40 and <0.60 for
35.3% of pairs, ≥0.20 and <0.40 for 45.9% of pairs, and
<0.20 for 7.6% of pairs (details of estimates and 95% conﬁ-
dence intervals are shown in Web Table 3). For the 29 FS
that had a published cutoff point, additional results with κ
calculated using these cutoffs are shown inWeb Table 4.
Prediction interval widths obtained with model B are plot-
ted as a heat map in Figure 2, grouped by frailty model cate-
gory. The narrowest median prediction interval was found
for the 40-item Frailty Index with model A (Table 5) and theTa
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Table 5. Cohen’s Kappa Coefﬁcients for Agreement Between Frailty Scores and Results of Bland-AltmanModel Analysis for Participants in
Wave 2 of the English Longitudinal Study of Ageing, 2004–2005
Frailty Model andMeasure Median κ
Width of Prediction Interval Absolute Error
M35FSa PFSb M35FSa PFSb
“Phenotype of frailty”model
Beaver DamEye Study Index 0.318 0.747 0.795 0.123 0.140
Physical Frailty Index 0.298 0.732 0.801 0.113 0.135
FiNDQuestionnaire 0.508 0.415 0.593 0.025 0.058
Frail Scale 0.391 0.421 0.598 0.099 0.090
Phenotype of Frailty 0.402 0.501 0.663 0.048 0.065
Modiﬁed Phenotype of Frailty 0.451 0.427 0.624 0.075 0.096
SOF Index 0.254 0.597 0.736 0.089 0.097
Short Physical Performance Battery 0.396 0.499 0.672 0.102 0.113
ZED1 (Physical Activity and Low Energy) 0.363 0.688 0.759 0.067 0.063
ZED2 (Physical Activity andWeight Loss) 0.191 0.760 0.818 0.057 0.061
ZED3 (Physical Activity and Low BMI) 0.195 0.730 0.907 0.050 0.063
Multidimensional model
Brief Frailty Index 0.316 0.629 0.746 0.073 0.085
Modiﬁed Frailty Score 0.293 0.454 0.640 0.076 0.096
CGAST 0.419 0.347 0.552 0.057 0.048
Conselice Study of Brain Aging Score 0.387 0.430 0.600 0.099 0.111
Edmonton Frail Scale 0.454 0.242 0.454 0.092 0.075
Frailty Staging System 0.447 0.500 0.621 0.054 0.068
G-8 geriatric screening tool 0.352 0.355 0.531 0.013 0.064
Groningen Frailty Indicator 0.513 0.280 0.492 0.014 0.065
Health Status Form 0.430 0.485 0.663 0.082 0.072
Static/Dynamic Frailty Index 0.389 0.429 0.612 0.104 0.120
Screening Instrument 0.344 0.479 0.662 0.061 0.053
Sherbrooke Postal Questionnaire 0.305 0.515 0.580 0.015 0.065
Inter-Frail Questionnaire 0.445 0.385 0.699 0.015 0.064
Tilburg Frailty Indicator 0.472 0.339 0.569 0.091 0.111
“Accumulation of deﬁcits”model
Comprehensive Geriatric Assessment 0.493 0.212 0.424 0.042 0.059
Evaluative Frailty Index for Physical Activity 0.536 0.219 0.462 0.024 0.061
40-item Frailty Index 0.535 0.201 0.450 0.035 0.060
70-item Frailty Index (SHARE) 0.518 0.231 0.468 0.021 0.063
Frailty Index (BLSA) 0.500 0.234 0.449 0.060 0.060
Long TermCare Survey Frailty Index 0.435 0.236 0.440 0.080 0.066
Disability model
WHOAFC and self-reported health 0.463 0.436 0.616 0.071 0.065
HRCAVulnerability Index 0.444 0.391 0.589 0.076 0.066
CSHAClinical Frailty Scale 0.380 0.561 0.721 0.086 0.093
Vulnerable Elders Survey 0.437 0.392 0.602 0.050 0.050
Abbreviations: BLSA, Beijing Longitudinal Study of Ageing; BMI, body mass index; CGAST, Comprehensive Geriatric Assessment Screening
Tests; CSHA, Canadian Study of Health and Aging; FiND, Frail Non-Disabled; HRCA, Hebrew Rehabilitation Center for Aged; M35FS, mean of 35
frailty scores; PFS, pair of frailty scores; SHARE, Survey of Health, Ageing and Retirement in Europe; SOF, Study of Osteoporotic Fractures;
WHOAFC,World Health Organization Assessment of Functional Capacity; ZED, Zutphen Elderly Study.
a Bland-Altman analysis with x-axis equal to the M35FS and y-axis equal to the difference between each score and M35FS; absolute error was
calculated at the median value of the M35FS.
b Bland-Altman analysis with x-axis equal to the mean of PFS and y-axis equal to the difference between each score and themean of PFS; abso-
lute error was calculated at themedian value of the mean of PFS.
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Comprehensive Geriatric Assessment with model B (Table 5
and Figure 2). Both FS belong to the “accumulation of deﬁ-
cits”model.
Figure 3 (grouped by model) shows a heat map of the abso-
lute error calculated with model B. The lowest absolute error
with model B was found for the Comprehensive Geriatric
Assessment Screening Tests and, withmodel A, the G-8 geriat-
ric screening tool (Table 5). Both FS belonged to the “multi-
dimensional” model (Table 5 and Figure 3). Web Figures 2–4
show results from the same analysis as Figures 1–3, grouped
according to the stated target population. Web Figures 5–11
are heat maps of κ values stratiﬁed by sex, age, and smoking
status. Plots of model B are shown in theWebAppendix.
DISCUSSION
We studied the cross-sectional agreement between 35 FS in
an elderly population and found a wide range of agreement.
Out of 595 pairs of scores, almost 90% had a κ value under
0.6. Our results, based on both traditional and modiﬁed Bland-
Altman models, indicated that FS belonging to the “accu-
mulation of deﬁcits” model with many variables had higher
median agreement (Figure 1) and narrower prediction inter-
vals (Figure 2) and that FS belonging to the “multidimen-
sional” model had lower absolute errors (Figure 3). Our
results support our initial hypothesis that different FS clas-
sify different subsets of the population as frail.
Using the published cutoff values for each frailty score,
we found very wide variation in the prevalence of frailty, as
previously reported by others (12, 54–56). Scores that deﬁne
solely frail and nonfrail categories generally yielded a higher
frailty prevalence than scores that also deﬁne an intermediate
“prefrail” state. Even though some variation is to be expected
due to the fact that scores have been developed according to
different underlying concepts of frailty, our ﬁnding of a 70-fold
difference between the highest prevalences (Short Physical Per-
formance Battery: 65.0% in men and 72.4% in women) and the
Figure 1. Agreement (calculated with Cohen’s κ) between pairs of frailty scores (595 combined pairs of scores) among participants in wave 2 of
the English Longitudinal Study of Ageing, 2004–2005. The plot is sorted by frailty model and then from highest (red) to lowest (blue) median value
of Cohen’s κ coefﬁcient. BDE, Beaver Dam Eye Study Index; BFI, Brief Frailty Index; BMI, body mass index; MFS, Modiﬁed Frailty Score; CGA,
Comprehensive Geriatric Assessment; CGAST, Comprehensive Geriatric Assessment Screening Tests; CSBA, Conselice Study of Brain Aging
Score; EFIP, Evaluative Frailty Index for Physical Activity; EFS, Edmonton Frail Scale; FI40, 40-item Frailty Index; FI70, 70-item Frailty Index;
FIBLSA, Frailty Index Beijing Longitudinal Study of Ageing; PFI, Physical Frailty Index; FiND, Frail Non-Disabled (FiND) Questionnaire; FS, Frail
Scale; FSS, Frailty Staging System; G8, G-8 geriatric screening tool; GFI, Groningen Frailty Indicator; HRCA, Hebrew Rehabilitation Center for
Aged Vulnerability Index; HSF, Health Status Form; NLTCS, National Long Term Care Survey Frailty Index; PHF, Phenotype of Frailty; MPHF,
Modiﬁed Phenotype of Frailty; SDFI, Static/Dynamic Frailty Index; SHCFS, Canadian Study of Health and Aging Clinical Frailty Scale; SI, Screen-
ing Instrument; SOF, Study of Osteoporotic Fractures; SPPB, Short Physical Performance Battery; SPQ, Sherbrooke Postal Questionnaire; IFQ,
Inter-Frail Questionnaire; TFI, Tilburg Frailty Indicator; VES13, Vulnerable Elders Survey; WHOAFC, World Health Organization Assessment of
Functional Capacity;WHRH,WHOAFC and self-reported health; ZED1, Zutphen Elderly Study (Physical Activity and Low Energy); ZED2, Zutphen
Elderly Study (Physical Activity andWeight Loss); ZED3, Zutphen Elderly Study (Physical Activity and LowBMI).
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lowest prevalences (Zutphen Elderly Study (Physical Activity
and Low BMI): 0.8% in men and 1.0% in women) indicates
that published estimates of frailty prevalence, and consequently
our insight into the magnitude of the frailty problem, is depen-
dent to an overwhelming degree on the chosen instrument and
cutoff level. Comparisons with prevalence estimates from other
populations, such as those published in 2012 in a systematic
review (55), therefore need to be undertaken with caution and
preferably only between studies using the same instrument.
Our ﬁndings also highlight that the general recommenda-
tion that scores and their cutoff levels be recalibrated (by mod-
iﬁcation of the weights attached to each item and/or revision
of the optimal cutoff level) before being applied outside their
original population is highly applicable and important in the
ﬁeld of frailty. When we regarded FS on a continuous scale
from 0 to 1, the between-score variation was still large but less
pronounced (a 2.7-fold difference in mean frailty score between
the highest (0.35) and the lowest (0.13) scores). This indicates
that the problem of the wide divergence in prevalence estimates
is due ﬁrstly to lack of generalizability of cutoff values across
different populations and secondly to different characteris-
tics of the scores themselves. The lack of a uniform under-
standing of what constitutes frailty is ultimately what
underlies the large number of different scores used to mea-
sure it and the resulting issues that arise when attempting to
compare results.
Given the outlined issues with the use of published cutoff
levels, we focused our study of agreement on identiﬁcation of
the 20% of individuals who are the most frail. We found that in
some cases agreement was as low as 0.1 (10%), which, with a
prevalence of 0.2, means that approximately 30% of indivi-
duals would be classiﬁed differently. The highest agreement
(0.83 or 83%) translates to about 6% of individuals being clas-
siﬁed differently, at the predeﬁned prevalence of 0.2. Only
11.3% of pairs of scores had a κ value of 0.6 or higher, indicat-
ing that only a small minority of score pairs would identify the
same individuals as being frail with an acceptable level of con-
sistency. In clinical practice, these low levels of agreement
Figure 2. Prediction interval widths obtained with Bland-Altman models for all 595 combined pairs of frailty scores, English Longitudinal Study of
Ageing, wave 2 (2004–2005). The narrowest prediction interval widths are shown in red, and the widest are shown in blue. The plot is sorted by
frailty model and then by the narrowest prediction interval. BDE, Beaver Dam Eye Study Index; BFI, Brief Frailty Index; BMI, body mass index;
MFS, Modiﬁed Frailty Score; CGA, Comprehensive Geriatric Assessment; CGAST, Comprehensive Geriatric Assessment Screening Tests;
CSBA, Conselice Study of Brain Aging Score; EFIP, Evaluative Frailty Index for Physical Activity; EFS, Edmonton Frail Scale; FI40, 40-item Frailty
Index; FI70, 70-item Frailty Index; FIBLSA, Frailty Index Beijing Longitudinal Study of Ageing; PFI, Physical Frailty Index; FiND, Frail Non-Disabled
(FiND) Questionnaire; FS, Frail Scale; FSS, Frailty Staging System; G8, G-8 geriatric screening tool; GFI, Groningen Frailty Indicator; HRCA,
Hebrew Rehabilitation Center for Aged Vulnerability Index; HSF, Health Status Form; NLTCS, National Long TermCare Survey Frailty Index; PHF,
Phenotype of Frailty; MPHF, Modiﬁed Phenotype of Frailty; SDFI, Static/Dynamic Frailty Index; SHCFS, Canadian Study of Health and Aging Clini-
cal Frailty Scale; SI, Screening Instrument; SOF, Study of Osteoporotic Fractures; SPPB, Short Physical Performance Battery; SPQ, Sherbrooke
Postal Questionnaire; IFQ, Inter-Frail Questionnaire; TFI, Tilburg Frailty Indicator; VES13, Vulnerable Elders Survey; WHOAFC, World Health
Organization Assessment of Functional Capacity; WHRH, WHOAFC and self-reported health; ZED1, Zutphen Elderly Study (Physical Activity and
Low Energy); ZED2, Zutphen Elderly Study (Physical Activity andWeight Loss); ZED3, Zutphen Elderly Study (Physical Activity and Low BMI).
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would lead to the selection of largely different people for fur-
ther examination or treatment, depending on which tool was
implemented.
As a summary measure of agreement, κ has the disadvan-
tage of valuing correct classiﬁcation of the presence or
absence of the condition in equal measure. Judgement of
whether or not this is appropriate will depend on the context
in which a score is used. If it is used as part of a sequence of
screening steps, sensitivity is likely to be more important
than speciﬁcity, while if the score is used to guide treatment
initiation, speciﬁcity will be equally important. Additionally,
in a research context, this measure depends on the prevalence
of the condition (with a very low prevalence, κ will be very
low, even with high agreement between raters) (57).
We examined agreement across the entire spectrum of
frailty based on both traditional and modiﬁed Bland-Altman
analyses. Traditional pairwise Bland-Altman models regard
the mean of each pair of measures as an indicator of the “true”
value. In our modiﬁed Bland-Altman models, we calculated
the M35FS to generate a global indicator of the “true” level of
frailty. Although use of the M35FS as a proxy for the “true”
level of frailty involves making a number of assumptions,
such as assigning equal importance to each of the studied
scores, we feel that this approach best captures the agreement
between each score and the global level of frailty in the
absence of an accepted gold standard. The complementary
pairwise analyses based on traditional Bland-Altman models
largely conﬁrmed the ﬁnding of better agreement for FS with
numerous variables and lower error for FS from the multidi-
mensional model category (Table 5).
Several scores tended to progressively under- or overesti-
mate frailty at higher levels of “true” frailty, indicating that
they would require recalibration not only of the distribution or
cutoff level but also of the relative weight attached to each
Figure 3. Absolute error (over-/underestimation) of frailty in the median frailty value from the modiﬁed Bland-Altman model obtained with all 595
combined pairs of frailty scores, English Longitudinal Study of Ageing, wave 2 (2004–2005). The over-/underestimation is the absolute value of the
intercept plus the product of the slope and the median. The intercept and slope are obtained from the Bland-Altman model. The median is calculated
as the median value of the mean of 2 frailty scores for each pair. The lowest absolute errors are shown in red, and the highest are shown in blue.
The plot is sorted by frailty model and then by the lowest absolute error. BDE, Beaver Dam Eye Study Index; BFI, Brief Frailty Index; BMI, body
mass index; MFS, Modiﬁed Frailty Score; CGA, Comprehensive Geriatric Assessment; CGAST, Comprehensive Geriatric Assessment Screening
Tests; CSBA, Conselice Study of Brain Aging Score; EFIP, Evaluative Frailty Index for Physical Activity; EFS, Edmonton Frail Scale; FI40, 40-item
Frailty Index; FI70, 70-item Frailty Index; FIBLSA, Frailty Index Beijing Longitudinal Study of Ageing; PFI, Physical Frailty Index; FiND, Frail Non-
Disabled (FiND) Questionnaire; FS, Frail Scale; FSS, Frailty Staging System; G8, G-8 geriatric screening tool; GFI, Groningen Frailty Indicator;
HRCA, Hebrew Rehabilitation Center for Aged Vulnerability Index; HSF, Health Status Form; NLTCS, National Long Term Care Survey Frailty Index;
PHF, Phenotype of Frailty; MPHF, Modiﬁed Phenotype of Frailty; SDFI, Static/Dynamic Frailty Index; SHCFS, Canadian Study of Health and Aging
Clinical Frailty Scale; SI, Screening Instrument; SOF, Study of Osteoporotic Fractures; SPPB, Short Physical Performance Battery; SPQ, Sher-
brooke Postal Questionnaire; IFQ, Inter-Frail Questionnaire; TFI, Tilburg Frailty Indicator; VES13, Vulnerable Elders Survey; WHOAFC, World
Health Organization Assessment of Functional Capacity; WHRH, WHOAFC and self-reported health; ZED1, Zutphen Elderly Study (Physical Activity
and Low Energy); ZED2, Zutphen Elderly Study (Physical Activity and Weight Loss); ZED3, Zutphen Elderly Study (Physical Activity and Low BMI).
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underlying variable to avoid producing biased frailty estimates
in the ELSA population. Several scores showed remarkably
wide prediction intervals, indicating a poor capacity to accu-
rately assess the “true” level of frailty.
The narrowest prediction intervals were observed for the
FS from the “accumulation of deﬁcits” model category,
which were also the FS with the best agreement across all
score pairs based on κ values. In general, scores based on a
larger number of variables tended to have narrower predic-
tion intervals and higher overall agreement, but with a certain
degree of underestimation in the higher frailty ranges. Scores
that were multidimensional tended to have less error at the
median point of frailty.
While features such as accuracy, overall agreement, and
bias are important considerations guiding a choice of score
for research or clinical practice, practical feasibility is likely
to be as important. Although we observed the highest overall
agreement between scores derived from numerous variables,
these scores may be difﬁcult to implement in practice due to
the high demands on time, expertise, and equipment required
to obtain a valid and complete set of the necessary data.
When we categorized our results by the intended setting
(clinical or community-based) in supplementary analyses,
we observed similar variability in agreement both within and
between these 2 kinds of settings (Web Figures 2 and 3).
Which score strikes the optimal balance between feasibility
and performance is likely to be different in each situation.
Our results may help guide these decisions.
The main strengths of the present study are that we analyzed
agreement between the most comprehensive list of FS exam-
ined to date in a large sample representative of an elderly gen-
eral population, based on data including self-reported and
objective measures of determinants and characteristics of
frailty.We applied 3 different approaches to the study of agree-
ment, ﬁnding broadly consistent results. In addition, we
applied multiple imputation, using a state-of-the art method.
The main limitation of our study is that in the absence of an
external gold standard, our analyses of agreement between the
continuous scores depended on an internal proxy for “true”
frailty, deﬁned either speciﬁcally for each pair of scores or
globally as the M35FS. Our adaptation of some scores to the
data available in ELSA may have led to some degree of distor-
tion in comparison with the original score deﬁnition. However,
this affected only a minority of scores and is unlikely to have
determined our main ﬁndings. Finally, due to the cross-sectional
design of the present analysis, we cannot draw conclusions
regarding dynamic features of the scores (such as longitudinal
stability) or about other aspects (such as external validity) with
regard to frailty outcomes.
Our comparative study of different features of agreement
in a wide set of published FS showed marked heterogeneity
in the degree to which various FS over-/underestimate frailty
and agree on the identiﬁcation of particular individuals as
frail. Different scores are based on different concepts of
frailty, and most pairs cannot be assumed to be interchange-
able. Research results based on different scores cannot be
compared, pooled, or summarized directly. Our results sup-
port a multidimensional concept of frailty that includes many
variables.
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